Crizotinib treatment effective against ROS1-positive lung cancer, study suggests
Monday, September 29, 2014 - 05:30
in Health & Medicine
Treatment with the targeted therapy drug crizotinib effectively halted the growth of lung tumors driven by rearrangements of the ROS1 gene in a small clinical trial.